Home > Boards > US Listed > Brokerages/Investment Banks > Tenzing Acquisition Corp. (TZAC)

So the target is Reviva Pharmaceuticals

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BiotechValues Member Profile
 
Followed By 340
Posts 10,238
Boards Moderated 2
Alias Born 06/23/07
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/15/2021 5:08:08 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/15/2021 4:44:19 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/15/2021 8:02:27 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/26/2021 7:01:27 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/21/2021 6:07:53 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/21/2021 6:06:39 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2021 4:31:23 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/16/2021 4:22:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 8:22:31 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2021 8:02:36 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/16/2021 6:05:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/16/2021 4:31:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/16/2021 4:31:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/16/2021 4:31:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/16/2021 4:17:14 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/14/2021 6:01:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/3/2021 5:31:00 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/3/2021 5:17:04 PM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 5/28/2021 4:10:08 PM
Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex) Edgar (US Regulatory) - 5/28/2021 4:08:08 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 5/25/2021 9:22:02 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 5/19/2021 7:22:29 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 5/17/2021 4:29:31 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 5/17/2021 4:28:14 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/17/2021 9:21:18 AM
BiotechValues   Wednesday, 07/22/20 11:42:23 AM
Re: None
Post # of 4 
So the target is Reviva Pharmaceuticals


Tenzing Acquisition Corp SPAC merging with Reiva Pharmaceuticals


https://finance.yahoo.com/news/tenzing-acquisition-corp-reviva-pharmaceuticals-115400189.html


Looks like a solid pipeline of phase 2 and 3 psych drugs.

http://revivapharma.com/product_pipeline/


How to value it though? Post merger enterprise valuation $119m uses $10 price for the calculation. According to last Q SEC filings, there are only 2.7m shares outstanding.

Nobody here yet- but would appreciate any thoughts on the valuation here, or (better yet) some comps.

Cheers!







Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences